NF-ΚB Activation as a Key Driver in Chronic Lymphocytic Leukemia Evolution to Richter’s Syndrome: Unraveling the Influence of Immune Microenvironment Dynamics
Genes · 2024
DOI: 10.3390/genes15111434 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2024. Verfasst von Paulo Rohan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Stem Cell Laboratory, Specialized Laboratories Division, Instituto Nacional de Câncer (INCA), Rio de Janeiro 20230-130, RJ, Brazil. Hauptthemen laut MEDLINE: Leukemia, Lymphocytic, Chronic, B-Cell, Tumor Microenvironment, NF-kappa B, Signal Transduction. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health.
Abstract (Originalsprache)
Background/Objectives: Chronic lymphocytic leukemia (CLL) is the most common adult leukemia in Western countries and it can progress to Richter’s syndrome (RS), a more aggressive condition. The NF-κB pathway is pivotal in CLL pathogenesis, driven mainly by B-cell receptor (BCR) signaling. However, recent evidence indicates that BCR signaling is reduced in RS, raising questions about whether and how NF-κB activity is maintained in RS. This study aims to elucidate the triggers and dynamics of NF-κB activation and the progression from CLL to RS.
Methods
Integrated single-cell RNA sequencing data from peripheral blood samples of four CLL–RS patients were analyzed. NF-κB pathway activity and gene expression profiles were assessed to determine changes in NF-κB components and their targets. Tumor microenvironment composition and cell–cell communication patterns were inferred to explore NF-κB regulatory mechanisms.
Results
RS samples showed increased proportions of malignant cells expressing NF-κB components, including NFKB1, NFKB2, RELA, IKBKG, MAP3K14, CHUK, and IKBKB, with significantly higher expression levels than in CLL. Enhanced NF-κB pathway activity in RS cells was associated with targets involved in immune modulation. The tumor microenvironment in RS displayed significant compositional changes, and signaling inference revealed enhanced cell–cell communication via BAFF and APRIL pathways, involving interactions with receptors such as BAFF-R and TACI on RS cells.
Conclusions
The findings from this study reveal an active state of NF-κB in RS and suggest that this state plays a critical role in the evolution of CLL to RS, which is modulated by alternative signaling pathways and the influence of the tumor microenvironment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Stem Cell Laboratory, Specialized Laboratories Division, Instituto Nacional de Câncer (INCA), Rio de Janeiro 20230-130, RJ, Brazil.
ORCID-Profile: Renata Binato, Eliana Abdelhay
Förderung
- Ministry of Health
Zitieren
APA
Rohan, P., Binato, R., & Abdelhay, E. (2024). NF-ΚB Activation as a Key Driver in Chronic Lymphocytic Leukemia Evolution to Richter’s Syndrome: Unraveling the Influence of Immune Microenvironment Dynamics. Genes. https://doi.org/10.3390/genes15111434
Vancouver
Rohan P, Binato R, Abdelhay E. NF-ΚB Activation as a Key Driver in Chronic Lymphocytic Leukemia Evolution to Richter’s Syndrome: Unraveling the Influence of Immune Microenvironment Dynamics. Genes. 2024. doi:10.3390/genes15111434
BibTeX
@article{Rohan2024,
author = {Rohan, Paulo and Binato, Renata and Abdelhay, Eliana},
title = {NF-ΚB Activation as a Key Driver in Chronic Lymphocytic Leukemia Evolution to Richter’s Syndrome: Unraveling the Influence of Immune Microenvironment Dynamics},
journal = {Genes},
year = {2024},
doi = {10.3390/genes15111434}
}
EUVIMED